Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02643550
Title Study of IPH2201 (Monalizumab) and Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Innate Pharma
Indications
Therapies
Age Groups: adult
Covered Countries USA | FRA

Facility Status City State Zip Country Details
University of California, Moores Cancer Center La Jolla California United States Details
Stanford Cancer Center Stanford California 94305 United States Details
University of Chicago Chicago Illinois 60637 United States Details
University of Maryland, Greenebaum Comprehensive Cancer Center Baltimore Maryland United States Details
Washington University School of Medicine Saint Louis Missouri United States Details
Icahn School of Medicine at Mount Sinaï New York New York 10029 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
Vanderbilt University Medical Center Nashville Tennessee United States Details
Centre Jean Perrin Clermont-Ferrand France Details
Centre Oscar Lambret Lille France Details
Centre Leon Berard Lyon France Details
Hopital La Timone Marseille France Details
Institut Regional du Cancer de Montpellier Montpellier France Details
Centre Antoine Lacassagne Nice France Details
Centre Eugene Marquis Rennes France Details
ICO Rene Gauducheau Saint-Herblain France Details
Institut Gustave Roussy Villejuif France Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field